2014 Q1 Form 10-K Financial Statement

#000114420414015803 Filed on March 14, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q4 2013
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.100M $2.970M $10.10M
YoY Change -15.32% 10.82% 16.49%
% of Gross Profit
Research & Development $4.487M $6.550M $25.68M
YoY Change -24.89% 16.55% 47.02%
% of Gross Profit
Depreciation & Amortization $5.000K $10.00K $17.00K
YoY Change 66.67% 466.67%
% of Gross Profit
Operating Expenses $6.582M $9.520M $35.78M
YoY Change 10.18% 14.7% 104.83%
Operating Profit -$6.582M -$9.524M -$35.78M
YoY Change -22.18% 14.76% 31.66%
Interest Expense $966.0K -$270.0K $1.923M
YoY Change 102.94% -27.03% 187.01%
% of Operating Profit
Other Income/Expense, Net -$788.0K -$1.378M
YoY Change
Pretax Income -$7.370M -$9.800M -$37.16M
YoY Change -16.82% 13.16% 34.59%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$7.370M -$9.798M -$37.16M
YoY Change -16.8% 13.09% 34.58%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$205.3K -$274.4K -$1.221M
COMMON SHARES
Basic Shares Outstanding 44.09M shares 35.61M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q1 2013 Q4 2013
SHORT-TERM ASSETS
Cash & Short-Term Investments $80.00M $99.50M $99.50M
YoY Change 81.41% 147.51% 147.51%
Cash & Equivalents $79.98M $99.52M $99.50M
Short-Term Investments
Other Short-Term Assets $500.0K $500.0K $500.0K
YoY Change -50.0% 25.0% 25.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $80.50M $100.0M $100.0M
YoY Change 78.5% 146.43% 146.31%
LONG-TERM ASSETS
Property, Plant & Equipment $69.00K $447.0K $400.0K
YoY Change -31.0% 776.47% 300.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $250.0K
YoY Change
Other Assets $70.00K $104.0K $100.0K
YoY Change -76.67% -70.2% -66.67%
Total Long-Term Assets $14.40M $551.0K $600.0K
YoY Change 3499.5% 37.75% 50.0%
TOTAL ASSETS
Total Short-Term Assets $80.50M $100.0M $100.0M
Total Long-Term Assets $14.40M $551.0K $600.0K
Total Assets $94.90M $100.6M $100.6M
YoY Change 108.58% 145.37% 145.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $872.0K $468.0K $500.0K
YoY Change 24.57% -54.52% -50.0%
Accrued Expenses $3.438M $4.430M $4.500M
YoY Change 49.48% 102.75% 95.65%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $6.200M $6.200M
YoY Change -100.0% 244.44% 244.44%
Total Short-Term Liabilities $4.335M $11.21M $11.20M
YoY Change -30.08% 118.43% 119.61%
LONG-TERM LIABILITIES
Long-Term Debt $14.00M $7.000M $7.000M
YoY Change 26.13% -43.55% -43.55%
Other Long-Term Liabilities $1.066M $1.077M $1.100M
YoY Change -28.93% -25.26% -21.43%
Total Long-Term Liabilities $1.066M $1.077M $8.100M
YoY Change -91.54% -25.26% -41.3%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.335M $11.21M $11.20M
Total Long-Term Liabilities $1.066M $1.077M $8.100M
Total Liabilities $19.41M $19.30M $19.30M
YoY Change 3.8% 1.82% 1.58%
SHAREHOLDERS EQUITY
Retained Earnings -$128.7M -$121.3M
YoY Change 44.14%
Common Stock $44.00K $40.00K
YoY Change 66.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $75.49M $81.28M $81.30M
YoY Change
Total Liabilities & Shareholders Equity $94.90M $100.6M $100.6M
YoY Change 108.57% 145.37% 145.37%

Cashflow Statement

Concept 2014 Q1 2013 Q4 2013
OPERATING ACTIVITIES
Net Income -$7.370M -$9.798M -$37.16M
YoY Change -16.8% 13.09% 34.58%
Depreciation, Depletion And Amortization $5.000K $10.00K $17.00K
YoY Change 66.67% 466.67%
Cash From Operating Activities -$6.070M -$7.140M -$29.65M
YoY Change -18.96% 0.56% 27.82%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $150.0K $40.00K
YoY Change -400.0% -25.93%
Acquisitions
YoY Change
Other Investing Activities -$250.0K -$150.0K -$150.0K
YoY Change -34.78% -34.78%
Cash From Investing Activities -$250.0K $0.00 -$188.0K
YoY Change -100.0% -32.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $481.0K $91.34M
YoY Change -95.89% 216.54%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -13.22M 390.0K $89.16M
YoY Change -216.48% 290.0% 120.07%
NET CHANGE
Cash From Operating Activities -6.070M -7.140M -$29.65M
Cash From Investing Activities -250.0K 0.000 -$188.0K
Cash From Financing Activities -13.22M 390.0K $89.16M
Net Change In Cash -19.54M -6.750M $59.32M
YoY Change -606.22% -7.28% 248.15%
FREE CASH FLOW
Cash From Operating Activities -$6.070M -$7.140M -$29.65M
Capital Expenditures $0.00 $150.0K $40.00K
Free Cash Flow -$6.070M -$7.290M -$29.69M
YoY Change -18.96% 3.4% 27.69%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 24.45pt"> <b><font style="FONT-SIZE: 10pt">Use of Estimates</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 24.45pt"> <b><font style="FONT-SIZE: 10pt"></font></b>&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 24.45pt"> <font style="FONT-SIZE: 10pt">The Company&#8217;s consolidated financial statements include certain amounts that are based on management&#8217;s best estimates and judgments. The Company&#8217;s significant estimates include, but are not limited to, useful lives assigned to long-lived assets, the valuation of its common stock (&#8220;Common stock&#8221;) prior to the Company becoming public and Common stock warrants, stock options, accrued expenses, provisions for income taxes and contingencies. Due to the uncertainty inherent in such estimates, actual results may differ from our estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 24.45pt"> <b><font style="FONT-SIZE: 10pt">Concentration of Risk</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 24.45pt"> <b><font style="FONT-SIZE: 10pt"></font></b>&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 24.45pt"> <font style="FONT-SIZE: 10pt">The Company is currently completely dependent on third party manufacturers for product supply. In particular, the Company currently relies exclusively on Ovamed GmbH (&#8220;Ovamed&#8221;) to supply it with its requirements of <i> Trichuris suis</i> ova (&#8220;TSO&#8221;). Ovamed is the sole supplier of this product, which it is currently producing at only one facility in Germany, where it is also producing product for third parties, including Dr.&#160;Falk Pharma GmbH (&#8220;Falk&#8221;). Ovamed also relies on certain other suppliers for materials and services. Similarly, the Company currently relies on BioReliance Corporation, Progenitor Cell Therapy LLC and other third parties for its CNDO&#150;109 product requirements. The Company&#8217;s clinical development programs would be adversely affected by a significant interruption in obtaining clinical trial supplies.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
447000 USD
CY2012Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
12386000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
18959000 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
393000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
40592000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
40199000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
51000 USD
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5090171 shares
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23160000 USD
CY2006Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2011 us-gaap Interest Paid
InterestPaid
53000 USD
CY2012 us-gaap Interest Paid
InterestPaid
421000 USD
CY2013Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
7017000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
19304000 USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11210000 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
40000 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
202580000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-121342000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
81278000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
100582000 USD
CY2012 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
3638000 USD
CY2013 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
5902000 USD
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
13414000 USD
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.34
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.76
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
641000 USD
CY2013Q4 cndo Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
1245000 USD
CY2012Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
0 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
99521000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
510000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
100031000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
349000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
104000 USD
CY2012Q4 us-gaap Assets
Assets
40992000 USD
CY2013Q4 us-gaap Assets
Assets
100582000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1029000 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
468000 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2185000 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4430000 USD
CY2012Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1799000 USD
CY2013Q4 us-gaap Notes Payable Current
NotesPayableCurrent
6203000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5132000 USD
CY2012Q4 cndo Other Long Term Liabilities
OtherLongTermLiabilities
1441000 USD
CY2013Q4 cndo Other Long Term Liabilities
OtherLongTermLiabilities
1077000 USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
24000 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
106193000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-84184000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
22033000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
40992000 USD
CY2013Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
190000 USD
CY2012 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3361 shares
CY2012Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
5750000 shares
CY2013Q4 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
1 pure
CY2012Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
63000 USD
CY2013Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
43000 USD
CY2013 cndo Percentage Of Tax Benefit Likely Of Being Realized
PercentageOfTaxBenefitLikelyOfBeingRealized
0.5 pure
CY2011 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-42221000 USD
CY2012 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-27610000 USD
CY2013 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-37158000 USD
CY2011 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7662984 shares
CY2012 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
21654984 shares
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
30429743 shares
CY2011 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-5.51
CY2011 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10206543 shares
CY2012 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3371161 shares
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
54000 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
467000 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20000 USD
CY2012Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1064000 USD
CY2013Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
450000 USD
CY2012Q4 us-gaap Supplemental Unemployment Benefits Severance Benefits
SupplementalUnemploymentBenefitsSeveranceBenefits
354000 USD
CY2013Q4 us-gaap Supplemental Unemployment Benefits Severance Benefits
SupplementalUnemploymentBenefitsSeveranceBenefits
1502000 USD
CY2012Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
320000 USD
CY2013Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
351000 USD
CY2012Q4 cndo Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
403000 USD
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
44000 USD
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
192000 USD
CY2012Q4 cndo Notes Term Charges Payable
NotesTermChargesPayable
398000 USD
CY2013Q4 cndo Notes Term Charges Payable
NotesTermChargesPayable
398000 USD
CY2012Q4 cndo Other Long Term Liabilities Related To Manufacturing Rights
OtherLongTermLiabilitiesRelatedToManufacturingRights
1043000 USD
CY2013Q4 cndo Other Long Term Liabilities Related To Manufacturing Rights
OtherLongTermLiabilitiesRelatedToManufacturingRights
679000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1441000 USD
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1077000 USD
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24400754 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39652950 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24400754 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39652950 shares
CY2011 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
1469000 USD
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2466590 shares
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
-550157 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3117777 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
3117777 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
2169444 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.31
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.31
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
3.75
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0 USD
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y6M14D
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y4M10D
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y4M10D
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P7Y10M13D
CY2011 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8583000 USD
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17468000 USD
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
25682000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
67691000 USD
CY2011 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5755000 USD
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8665000 USD
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10098000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26377000 USD
CY2011 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
20706000 USD
CY2012 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
1043000 USD
CY2013 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
21749000 USD
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
-35044000 USD
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-27176000 USD
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-35780000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-115817000 USD
CY2011 us-gaap Investment Income Interest
InvestmentIncomeInterest
165000 USD
CY2012 us-gaap Investment Income Interest
InvestmentIncomeInterest
236000 USD
CY2013 us-gaap Investment Income Interest
InvestmentIncomeInterest
545000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
1025000 USD
CY2011 us-gaap Interest Expense
InterestExpense
74000 USD
CY2012 us-gaap Interest Expense
InterestExpense
670000 USD
CY2013 us-gaap Interest Expense
InterestExpense
1923000 USD
us-gaap Interest Expense
InterestExpense
5876000 USD
CY2011 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 USD
CY2012 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 USD
CY2013 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
733000 USD
CY2011 cndo Warrant Expense
WarrantExpense
1407000 USD
CY2012 cndo Warrant Expense
WarrantExpense
0 USD
CY2013 cndo Warrant Expense
WarrantExpense
0 USD
cndo Warrant Expense
WarrantExpense
1407000 USD
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-36360000 USD
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-27610000 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-37158000 USD
us-gaap Net Income Loss
NetIncomeLoss
-121342000 USD
CY2011 us-gaap Convertible Preferred Dividends Net Of Tax
ConvertiblePreferredDividendsNetOfTax
-5861000 USD
CY2012 us-gaap Convertible Preferred Dividends Net Of Tax
ConvertiblePreferredDividendsNetOfTax
0 USD
CY2013 us-gaap Convertible Preferred Dividends Net Of Tax
ConvertiblePreferredDividendsNetOfTax
0 USD
us-gaap Convertible Preferred Dividends Net Of Tax
ConvertiblePreferredDividendsNetOfTax
-5861000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-127203000 USD
CY2011 cndo Noncash Interest
NoncashInterest
0 USD
CY2012 cndo Noncash Interest
NoncashInterest
130000 USD
CY2013 cndo Noncash Interest
NoncashInterest
536000 USD
cndo Noncash Interest
NoncashInterest
2434000 USD
CY2011 cndo Noncash Interest Related Parties
NoncashInterestRelatedParties
0 USD
CY2012 cndo Noncash Interest Related Parties
NoncashInterestRelatedParties
0 USD
CY2013 cndo Noncash Interest Related Parties
NoncashInterestRelatedParties
0 USD
cndo Noncash Interest Related Parties
NoncashInterestRelatedParties
286000 USD
CY2011 cndo Contribution Of Services By Stockholder
ContributionOfServicesByStockholder
30000 USD
CY2012 cndo Contribution Of Services By Stockholder
ContributionOfServicesByStockholder
0 USD
CY2013 cndo Contribution Of Services By Stockholder
ContributionOfServicesByStockholder
0 USD
cndo Contribution Of Services By Stockholder
ContributionOfServicesByStockholder
130000 USD
CY2011 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
CY2012 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
CY2013 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
121000 USD
CY2011 cndo Change In Fair Value Of Common Stock Warrant Liability
ChangeInFairValueOfCommonStockWarrantLiability
0 USD
CY2012 cndo Change In Fair Value Of Common Stock Warrant Liability
ChangeInFairValueOfCommonStockWarrantLiability
0 USD
CY2013 cndo Change In Fair Value Of Common Stock Warrant Liability
ChangeInFairValueOfCommonStockWarrantLiability
0 USD
cndo Change In Fair Value Of Common Stock Warrant Liability
ChangeInFairValueOfCommonStockWarrantLiability
-234000 USD
CY2011 cndo Change In Fair Value Of Embedded Conversion Feature
ChangeInFairValueOfEmbeddedConversionFeature
0 USD
CY2012 cndo Change In Fair Value Of Embedded Conversion Feature
ChangeInFairValueOfEmbeddedConversionFeature
0 USD
CY2013 cndo Change In Fair Value Of Embedded Conversion Feature
ChangeInFairValueOfEmbeddedConversionFeature
0 USD
cndo Change In Fair Value Of Embedded Conversion Feature
ChangeInFairValueOfEmbeddedConversionFeature
831000 USD
CY2011 cndo Change In Preferred Stock Warrant Liability
ChangeInPreferredStockWarrantLiability
-1407000 USD
CY2012 cndo Change In Preferred Stock Warrant Liability
ChangeInPreferredStockWarrantLiability
0 USD
CY2013 cndo Change In Preferred Stock Warrant Liability
ChangeInPreferredStockWarrantLiability
0 USD
cndo Change In Preferred Stock Warrant Liability
ChangeInPreferredStockWarrantLiability
-1407000 USD
CY2011 us-gaap Depreciation
Depreciation
22000 USD
CY2012 us-gaap Depreciation
Depreciation
3000 USD
CY2013 us-gaap Depreciation
Depreciation
17000 USD
us-gaap Depreciation
Depreciation
61000 USD
CY2011 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
160000 USD
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
238000 USD
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
117000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
570000 USD
CY2011 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1915000 USD
CY2012 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-260000 USD
CY2013 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1184000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4398000 USD
CY2011 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10952000 USD
CY2012 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-23194000 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-29646000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-76738000 USD
CY2011 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
54000 USD
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
40000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
135000 USD
CY2011 us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
3843000 USD
CY2012 us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
0 USD
CY2013 us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
0 USD
us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
3843000 USD
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3843000 USD
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-279000 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-188000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4351000 USD
CY2011 cndo Proceeds From Notes Payable Related Parties
ProceedsFromNotesPayableRelatedParties
0 USD
CY2012 cndo Proceeds From Notes Payable Related Parties
ProceedsFromNotesPayableRelatedParties
0 USD
CY2013 cndo Proceeds From Notes Payable Related Parties
ProceedsFromNotesPayableRelatedParties
0 USD
cndo Proceeds From Notes Payable Related Parties
ProceedsFromNotesPayableRelatedParties
570000 USD
CY2011 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
CY2012 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
15000000 USD
CY2013 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
15000000 USD
CY2011 cndo Payment For Notes Payable Related Party
PaymentForNotesPayableRelatedParty
0 USD
CY2012 cndo Payment For Notes Payable Related Party
PaymentForNotesPayableRelatedParty
0 USD
CY2013 cndo Payment For Notes Payable Related Party
PaymentForNotesPayableRelatedParty
0 USD
cndo Payment For Notes Payable Related Party
PaymentForNotesPayableRelatedParty
570000 USD
CY2011 cndo Payment Of Notes Payable Asset Purchase Agreement
PaymentOfNotesPayableAssetPurchaseAgreement
0 USD
CY2012 cndo Payment Of Notes Payable Asset Purchase Agreement
PaymentOfNotesPayableAssetPurchaseAgreement
750000 USD
CY2013 cndo Payment Of Notes Payable Asset Purchase Agreement
PaymentOfNotesPayableAssetPurchaseAgreement
0 USD
cndo Payment Of Notes Payable Asset Purchase Agreement
PaymentOfNotesPayableAssetPurchaseAgreement
750000 USD
CY2011 cndo Proceeds From Notes Payable To Related Parties
ProceedsFromNotesPayableToRelatedParties
0 USD
CY2012 cndo Proceeds From Notes Payable To Related Parties
ProceedsFromNotesPayableToRelatedParties
0 USD
CY2013 cndo Proceeds From Notes Payable To Related Parties
ProceedsFromNotesPayableToRelatedParties
0 USD
cndo Proceeds From Notes Payable To Related Parties
ProceedsFromNotesPayableToRelatedParties
2221000 USD
CY2011 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
25784000 USD
CY2012 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
0 USD
CY2013 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
0 USD
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
25784000 USD
CY2011 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
CY2012 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
CY2013 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
80000 USD
CY2011 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 USD
CY2012 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 USD
CY2013 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
80000 USD
CY2011 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
CY2012 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
CY2013 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
7570000 USD
CY2011 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2012 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2013 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
737000 USD
CY2011 us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
0 USD
CY2012 us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
0 USD
CY2013 us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
0 USD
us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
-600000 USD
CY2011 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
193000 USD
CY2012 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
28855000 USD
CY2013 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
92399000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
121452000 USD
CY2011 cndo Payment Of Costs Related To Issuance Of Common Stock
PaymentOfCostsRelatedToIssuanceOfCommonStock
0 USD
CY2012 cndo Payment Of Costs Related To Issuance Of Common Stock
PaymentOfCostsRelatedToIssuanceOfCommonStock
2305000 USD
CY2013 cndo Payment Of Costs Related To Issuance Of Common Stock
PaymentOfCostsRelatedToIssuanceOfCommonStock
1898000 USD
cndo Payment Of Costs Related To Issuance Of Common Stock
PaymentOfCostsRelatedToIssuanceOfCommonStock
4203000 USD
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
23093000 USD
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
40512000 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
89156000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
180610000 USD
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
8298000 USD
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
17039000 USD
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
59322000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
99521000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14862000 USD
CY2013 us-gaap Interest Paid
InterestPaid
1387000 USD
us-gaap Interest Paid
InterestPaid
1949000 USD
CY2011 cndo Assumed Note Related To Asset Purchase
AssumedNoteRelatedToAssetPurchase
750000 USD
CY2012 cndo Assumed Note Related To Asset Purchase
AssumedNoteRelatedToAssetPurchase
0 USD
CY2013 cndo Assumed Note Related To Asset Purchase
AssumedNoteRelatedToAssetPurchase
0 USD
cndo Assumed Note Related To Asset Purchase
AssumedNoteRelatedToAssetPurchase
750000 USD
CY2013 dei Document Type
DocumentType
10-K
CY2013 dei Amendment Flag
AmendmentFlag
false
CY2013 dei Document Period End Date
DocumentPeriodEndDate
2013-12-31
CY2013 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2013 dei Trading Symbol
TradingSymbol
CNDO
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
44086387 shares
CY2013 dei Entity Registrant Name
EntityRegistrantName
CORONADO BIOSCIENCES INC
CY2013 dei Entity Central Index Key
EntityCentralIndexKey
0001429260
CY2013 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2013 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2013 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2013 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2013Q2 dei Entity Public Float
EntityPublicFloat
162039807 USD
CY2011 cndo Increase Decrease In Interest Payable Related Parties
IncreaseDecreaseInInterestPayableRelatedParties
-19000 USD
CY2012 cndo Increase Decrease In Interest Payable Related Parties
IncreaseDecreaseInInterestPayableRelatedParties
19000 USD
CY2013 cndo Increase Decrease In Interest Payable Related Parties
IncreaseDecreaseInInterestPayableRelatedParties
0 USD
cndo Increase Decrease In Interest Payable Related Parties
IncreaseDecreaseInInterestPayableRelatedParties
0 USD
CY2011 cndo Payment To Deposit For Leasehold Improvement
PaymentToDepositForLeaseholdImprovement
0 USD
CY2012 cndo Payment To Deposit For Leasehold Improvement
PaymentToDepositForLeaseholdImprovement
225000 USD
CY2013 cndo Payment To Deposit For Leasehold Improvement
PaymentToDepositForLeaseholdImprovement
148000 USD
cndo Payment To Deposit For Leasehold Improvement
PaymentToDepositForLeaseholdImprovement
373000 USD
CY2011 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
0 USD
CY2012 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
119000 USD
CY2013 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-10000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
109000 USD
CY2012Q4 cndo Stock Issuance Maximum Amount Of Proceeds Approved
StockIssuanceMaximumAmountOfProceedsApproved
30000000 USD
CY2012Q3 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
14700000 USD
CY2012Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
15000000 USD
CY2013 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
373000 USD
CY2011 cndo Payment Of Prinicipal Of Hercules Note
PaymentOfPrinicipalOfHerculesNote
0 USD
CY2012 cndo Payment Of Prinicipal Of Hercules Note
PaymentOfPrinicipalOfHerculesNote
0 USD
CY2013 cndo Payment Of Prinicipal Of Hercules Note
PaymentOfPrinicipalOfHerculesNote
1345000 USD
cndo Payment Of Prinicipal Of Hercules Note
PaymentOfPrinicipalOfHerculesNote
1345000 USD
CY2011 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
CY2012 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
288000 USD
CY2013 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
288000 USD
CY2012Q4 cndo Other Short Term Liabilities Related To Manufacturing Rights
OtherShortTermLiabilitiesRelatedToManufacturingRights
0 USD
CY2013Q4 cndo Other Short Term Liabilities Related To Manufacturing Rights
OtherShortTermLiabilitiesRelatedToManufacturingRights
500000 USD
CY2013 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.04 pure
CY2012 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
85000 USD
CY2013 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
107000 USD
CY2012Q4 cndo Related Party Other Investment Percentage In Entity By Principal Stockholder Or Director
RelatedPartyOtherInvestmentPercentageInEntityByPrincipalStockholderOrDirector
0.141 pure
CY2013Q4 cndo Related Party Other Investment Percentage In Entity By Principal Stockholder Or Director
RelatedPartyOtherInvestmentPercentageInEntityByPrincipalStockholderOrDirector
0.141 pure
CY2014Q1 cndo Related Party Other Investment Percentage In Entity By Familys Of Principal Stockholder Or Director
RelatedPartyOtherInvestmentPercentageInEntityByFamilysOfPrincipalStockholderOrDirector
0.150 pure
CY2013 cndo Underwriting Commission Incurred
UnderwritingCommissionIncurred
187000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
351000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
365000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
291000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
202000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
22000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1231000 USD
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-6581000 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-8458000 USD
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6465000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-10294000 USD
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5831000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7504000 USD
CY2012Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-8299000 USD
CY2013Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-9524000 USD
CY2012Q1 cndo Nonoperating Income Expense Including Interest Income Expense Net
NonoperatingIncomeExpenseIncludingInterestIncomeExpenseNet
25000 USD
CY2013Q1 cndo Nonoperating Income Expense Including Interest Income Expense Net
NonoperatingIncomeExpenseIncludingInterestIncomeExpenseNet
-400000 USD
CY2012Q2 cndo Nonoperating Income Expense Including Interest Income Expense Net
NonoperatingIncomeExpenseIncludingInterestIncomeExpenseNet
10000 USD
CY2013Q2 cndo Nonoperating Income Expense Including Interest Income Expense Net
NonoperatingIncomeExpenseIncludingInterestIncomeExpenseNet
-376000 USD
CY2012Q3 cndo Nonoperating Income Expense Including Interest Income Expense Net
NonoperatingIncomeExpenseIncludingInterestIncomeExpenseNet
-104000 USD
CY2013Q3 cndo Nonoperating Income Expense Including Interest Income Expense Net
NonoperatingIncomeExpenseIncludingInterestIncomeExpenseNet
-328000 USD
CY2012Q4 cndo Nonoperating Income Expense Including Interest Income Expense Net
NonoperatingIncomeExpenseIncludingInterestIncomeExpenseNet
-365000 USD
CY2013Q4 cndo Nonoperating Income Expense Including Interest Income Expense Net
NonoperatingIncomeExpenseIncludingInterestIncomeExpenseNet
-274000 USD
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-6556000 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-8858000 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-6455000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-10670000 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-5935000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-7832000 USD
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
-8664000 USD
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
-9798000 USD
CY2012Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.35
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.35
CY2012Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.34
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.38
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
CY2012Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.36
CY2013Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.27
CY2011 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
165000 USD
CY2012 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
93000 USD
CY2013 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
284000 USD
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights
One-third of the shares underlying the option were to vest on December 28, 2013 and each annual anniversary thereafter, subject to Dr. Weisman&#8217;s continued employment with the Company.
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
19572 USD
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
31450 USD
CY2011 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
0 USD
CY2012 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
609000 USD
CY2013 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
1903000 USD
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
3544000 USD
CY2011 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
74000 USD
CY2012 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
55000 USD
CY2013 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
0 USD
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
503000 USD
CY2012Q4 cndo Deferred Tax Assets Amortization Of Upfront Fees
DeferredTaxAssetsAmortizationOfUpfrontFees
3087 USD
CY2013Q4 cndo Deferred Tax Assets Amortization Of Upfront Fees
DeferredTaxAssetsAmortizationOfUpfrontFees
2865 USD
CY2011 cndo Amortization Of Embedded Conversion Feature
AmortizationOfEmbeddedConversionFeature
0 USD
CY2012 cndo Amortization Of Embedded Conversion Feature
AmortizationOfEmbeddedConversionFeature
0 USD
CY2013 cndo Amortization Of Embedded Conversion Feature
AmortizationOfEmbeddedConversionFeature
0 USD
cndo Amortization Of Embedded Conversion Feature
AmortizationOfEmbeddedConversionFeature
831000 USD
CY2011 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 USD
CY2012 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
6000 USD
CY2013 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
20000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
764000 USD
CY2012Q4 cndo Deferred Tax Assets Amortization Of In Process Research And Development
DeferredTaxAssetsAmortizationOfInProcessResearchAndDevelopment
407 USD
CY2013Q4 cndo Deferred Tax Assets Amortization Of In Process Research And Development
DeferredTaxAssetsAmortizationOfInProcessResearchAndDevelopment
460 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
1522 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
2827 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
622 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
854 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
991 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
2686 USD
CY2012Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
26201 USD
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
41142 USD
CY2012Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
26201 USD
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
41142 USD
CY2012Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2011 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2011 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.05 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.04 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.04 pure
CY2011 cndo Effective Income Tax Rate Reconciliation Acquired Net Operating Losses Nol
EffectiveIncomeTaxRateReconciliationAcquiredNetOperatingLossesNol
0.09 pure
CY2012 cndo Effective Income Tax Rate Reconciliation Acquired Net Operating Losses Nol
EffectiveIncomeTaxRateReconciliationAcquiredNetOperatingLossesNol
0 pure
CY2013 cndo Effective Income Tax Rate Reconciliation Acquired Net Operating Losses Nol
EffectiveIncomeTaxRateReconciliationAcquiredNetOperatingLossesNol
0 pure
CY2011 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.02 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.01 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.04 pure
CY2011 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.21 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.02 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.02 pure
CY2011 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.02 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.05 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.01 pure
CY2011 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2012 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2011Q4 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
11496186 shares
CY2007Q2 cndo Stock Issued To Founders Shares
StockIssuedToFoundersShares
2125096 shares
CY2007Q2 cndo Stock Issued To Founders Par Value
StockIssuedToFoundersParValue
0.001
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2009 us-gaap Share Based Goods And Nonemployee Services Transaction Quantity Of Securities Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued
5000 shares
CY2010 us-gaap Share Based Goods And Nonemployee Services Transaction Quantity Of Securities Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued
23836 shares
CY2010 cndo Share Based Goods And Nonemployee Services Transaction Fair Value Of Securities Issued
ShareBasedGoodsAndNonemployeeServicesTransactionFairValueOfSecuritiesIssued
82000 USD
CY2011 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
193000 USD
CY2011Q2 cndo Issuance Of Common Stock Special Dividend To Series Convertible Preferred Stock Shares
IssuanceOfCommonStockSpecialDividendToSeriesConvertiblePreferredStockShares
2178917 shares
CY2013 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
10558422 shares
CY2012Q2 cndo Stock Issued During Period Shares For Over Allotment Option Exercised By Underwriter
StockIssuedDuringPeriodSharesForOverAllotmentOptionExercisedByUnderwriter
750000 shares
CY2012Q2 cndo Stock Issued During Period New Issues Price Per Share
StockIssuedDuringPeriodNewIssuesPricePerShare
5.00
CY2011 cndo Effective Incometax Rate Reconciliation Prior Year State Net Operating Loss True Up
EffectiveIncometaxRateReconciliationPriorYearStateNetOperatingLossTrueUp
0.01 pure
CY2012 cndo Effective Incometax Rate Reconciliation Prior Year State Net Operating Loss True Up
EffectiveIncometaxRateReconciliationPriorYearStateNetOperatingLossTrueUp
0.02 pure
CY2012 cndo Effective Income Tax Rate Reconciliation Prior Year Federa Net Operating Loss True Up
EffectiveIncomeTaxRateReconciliationPriorYearFederaNetOperatingLossTrueUp
0.03 pure
CY2013 cndo Effective Income Tax Rate Reconciliation Prior Year Federa Net Operating Loss True Up
EffectiveIncomeTaxRateReconciliationPriorYearFederaNetOperatingLossTrueUp
0.01 pure
CY2012Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
26400000 USD
CY2011 cndo Effective Income Tax Rate Reconciliation State Rate Change
EffectiveIncomeTaxRateReconciliationStateRateChange
0.03 pure
CY2010 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
700000 USD
CY2012Q4 cndo Error Related To Taxation Overstatement Of Gross Deferred Tax Asset Amount
ErrorRelatedToTaxationOverstatementOfGrossDeferredTaxAssetAmount
3600000 USD
CY2012Q4 cndo Error Related To Taxation Understatement Of Valuation Amount
ErrorRelatedToTaxationUnderstatementOfValuationAmount
3600000 USD
CY2013Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
6203000 USD
CY2013Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
6866000 USD
CY2013Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
587000 USD
CY2012 cndo Tax Payer Relief Act Research Credit Extension Period
TaxPayerReliefActResearchCreditExtensionPeriod
P2Y
CY2012Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
5.72
CY2012Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
20000 shares
CY2012Q3 cndo Class Of Warrant Or Right Fair Value Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightFairValueOfSecuritiesCalledByWarrantsOrRights
92000 USD
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2519070 shares
CY2012Q3 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
1.0451 pure
CY2012Q3 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0106 pure
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.37
CY2012Q3 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0 pure
CY2012Q3 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P6Y
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
329000 USD
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2860000 USD
CY2010Q3 cndo Repayment Premium Senior Convertible Notes
RepaymentPremiumSeniorConvertibleNotes
0.429 pure
CY2011Q1 us-gaap Repayments Of Assumed Debt
RepaymentsOfAssumedDebt
400000 USD
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
7303280 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
996720 shares
CY2013 cndo Share Based Compensation Arrangement By Share Based Payment Award Contractual Term Of Award
ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTermOfAward
P10Y
CY2013Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
3400000 USD
CY2013 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y3M18D
CY2011Q4 cndo Employee Stock Purchase Plan Authorized Number Of Shares
EmployeeStockPurchasePlanAuthorizedNumberOfShares
200000 shares
CY2013Q4 cndo Employee Stock Purchase Plan Authorized Number Of Shares
EmployeeStockPurchasePlanAuthorizedNumberOfShares
200000 shares
CY2013Q4 cndo Employee Stock Purchase Plan Offering Fair Value Reckoning Percentage
EmployeeStockPurchasePlanOfferingFairValueReckoningPercentage
0.85 pure
CY2011Q4 cndo Employee Stock Purchase Plan Offering Fair Value Reckoning Percentage
EmployeeStockPurchasePlanOfferingFairValueReckoningPercentage
0.85 pure
CY2013Q4 cndo Employee Stock Purchase Plan Offering Fair Value Reckoning Percentage
EmployeeStockPurchasePlanOfferingFairValueReckoningPercentage
0.85 pure
CY2013Q4 cndo Employee Stock Purchase Plan Number Of Shares Purchased By Employees
EmployeeStockPurchasePlanNumberOfSharesPurchasedByEmployees
49214 shares
CY2012Q4 cndo Employee Stock Purchase Plan Number Of Shares Available For Future Sale
EmployeeStockPurchasePlanNumberOfSharesAvailableForFutureSale
95000 shares
CY2013Q4 cndo Employee Stock Purchase Plan Number Of Shares Available For Future Sale
EmployeeStockPurchasePlanNumberOfSharesAvailableForFutureSale
46000 shares
CY2012 cndo Employee Stock Purchase Plan Compensation Expense Recognized
EmployeeStockPurchasePlanCompensationExpenseRecognized
95000 USD
CY2013 cndo Employee Stock Purchase Plan Compensation Expense Recognized
EmployeeStockPurchasePlanCompensationExpenseRecognized
46000 USD
CY2007 us-gaap Net Income Loss
NetIncomeLoss
-2644000 USD
CY2008 us-gaap Net Income Loss
NetIncomeLoss
-3799000 USD
CY2009 us-gaap Net Income Loss
NetIncomeLoss
-3666000 USD
CY2010 us-gaap Net Income Loss
NetIncomeLoss
-9982000 USD
us-gaap Net Income Loss
NetIncomeLoss
-123000 USD
CY2007 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2000 USD
CY2007 cndo Issuance Of Restricted Common Stock To Non Employees
IssuanceOfRestrictedCommonStockToNonEmployees
2000 USD
CY2007 cndo Issuance Of Restricted Common Stock To Employees
IssuanceOfRestrictedCommonStockToEmployees
1000 USD
CY2013 cndo Issuance Of Restricted Common Stock To Employees
IssuanceOfRestrictedCommonStockToEmployees
0 USD
CY2007 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
13000 USD
CY2008 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
25000 USD
CY2009 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
39000 USD
CY2010 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
2329000 USD
CY2011 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
1469000 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
3961000 USD
CY2013Q3 cndo Stock Issuance Maximum Amount Of Proceeds Approved
StockIssuanceMaximumAmountOfProceedsApproved
200000000 USD
CY2012Q3 cndo Stock Issuance Maximum Amount Of Proceeds Approved
StockIssuanceMaximumAmountOfProceedsApproved
75000000 USD
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
-1317726 shares
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.51
CY2008Q4 us-gaap Stockholders Equity
StockholdersEquity
5000 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
19132000 USD
CY2006Q4 us-gaap Stockholders Equity
StockholdersEquity
-123000 USD
CY2008Q4 us-gaap Shares Outstanding
SharesOutstanding
4762266 shares
CY2013 cndo Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
1000 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
5902000 USD
CY2008 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
20000 USD
CY2009 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
40000 USD
CY2010 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
40000 USD
CY2011 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
30000 USD
CY2010 cndo Issuance Of Convertible Preferred Stock Upon Conversion Of Debt And Accrued Interest
IssuanceOfConvertiblePreferredStockUponConversionOfDebtAndAccruedInterest
0 USD
CY2010 cndo Costs Related To Issuance Of Preferred Stock Series Including Common Stock Warrants
CostsRelatedToIssuanceOfPreferredStockSeriesIncludingCommonStockWarrants
621000 USD
CY2010 cndo Reclassification Of Warrant Liability At Fair Value
ReclassificationOfWarrantLiabilityAtFairValue
234000 USD
CY2010 cndo Change In Fair Value Of Embedded Conversion Feature Related To Related Party Notes And Senior Convertible Notes
ChangeInFairValueOfEmbeddedConversionFeatureRelatedToRelatedPartyNotesAndSeniorConvertibleNotes
831000 USD
CY2010 cndo Issuance Of Common Stock To Non Employees For Services
IssuanceOfCommonStockToNonEmployeesForServices
82000 USD
CY2011 cndo Issuance Of Common Stock Dividend To Preferred Stock
IssuanceOfCommonStockDividendToPreferredStock
0 USD
CY2011 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
193000 USD
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
970000 USD
CY2011 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
2693000 USD
CY2012 us-gaap Stock Issued During Period Value Issued For Cash
StockIssuedDuringPeriodValueIssuedForCash
28750000 USD
CY2012 cndo Stock Issuance Cost
StockIssuanceCost
2305000 USD
CY2012 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
87000 USD
CY2013 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
92000 USD
CY2012 cndo Stock Issued During Period Shares Issued For Cash At Market Cost Value
StockIssuedDuringPeriodSharesIssuedForCashAtMarketCostValue
19000 USD
CY2013 cndo Stock Issued During Period Shares Issued For Cash At Market Cost Value
StockIssuedDuringPeriodSharesIssuedForCashAtMarketCostValue
91337000 USD
CY2010 cndo Issuance Of Common Stock Warrants To Non Employees For Services
IssuanceOfCommonStockWarrantsToNonEmployeesForServices
38000 USD
CY2009Q4 us-gaap Stockholders Equity
StockholdersEquity
-15897000 USD
CY2006Q2 us-gaap Stockholders Equity
StockholdersEquity
0 USD
CY2007Q4 us-gaap Stockholders Equity
StockholdersEquity
-2749000 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
66000 USD
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
2200000 USD
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
3.77 USD
CY2013Q4 cndo Common Stock Offering Price
CommonStockOfferingPrice
70000000 USD
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
478000 USD
CY2011 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.28 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.33 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.4 pure
CY2011 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
0 USD
CY2012 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
0 USD
CY2013 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
4000 USD
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
4000 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
-1000 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
-1899000 USD
CY2013Q2 cndo Stock Issuance Maximum Amount Of Proceeds Approved
StockIssuanceMaximumAmountOfProceedsApproved
45000000 USD

Files In Submission

Name View Source Status
0001144204-14-015803-index-headers.html Edgar Link pending
0001144204-14-015803-index.html Edgar Link pending
0001144204-14-015803.txt Edgar Link pending
0001144204-14-015803-xbrl.zip Edgar Link pending
cndo-20131231.xml Edgar Link completed
cndo-20131231.xsd Edgar Link pending
cndo-20131231_cal.xml Edgar Link unprocessable
cndo-20131231_def.xml Edgar Link unprocessable
cndo-20131231_lab.xml Edgar Link unprocessable
cndo-20131231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ft0001img-2.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v365741_10k.htm Edgar Link pending
v365741_ex10-57.htm Edgar Link pending
v365741_ex10-58.htm Edgar Link pending
v365741_ex10-59.htm Edgar Link pending
v365741_ex21-1.htm Edgar Link pending
v365741_ex23-1.htm Edgar Link pending
v365741_ex3-8.htm Edgar Link pending
v365741_ex31-1.htm Edgar Link pending
v365741_ex31-2.htm Edgar Link pending
v365741_ex32-1.htm Edgar Link pending
v365741_ex32-2.htm Edgar Link pending